Literature DB >> 18288642

Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray.

Loleta D Harris1, Jorge De La Cerda, Tomasz Tuziak, Daniel Rosen, Lianchun Xiao, Yu Shen, Anita L Sabichi, Bogdan Czerniak, H Barton Grossman.   

Abstract

Dysregulation of Akt, PTEN, Drg-1, Cx-26, and L-plastin expression appear to be important in the progression of various cancers. Their expression in bladder cancer has not been well characterized. To assess the expression of these genes and their relationship to the outcome of bladder cancer, we used a bladder cancer tissue microarray (TMA) of 251 transitional cell carcinomas. We quantitated immunohistochemical staining of each protein using both automated and manual methods and correlated the expression levels with the clinicopathologic characteristics of the tumor and patient survival. Overall, the results from both automated and manual analyses were similar. We found a significant correlation between the expression of PTEN, Cx-26 and L-plastin with known clinically important pathologic features of bladder cancer (tumor grade, stage, and growth pattern). Aberrant localization patterns of Cx-26 and Drg-1 were observed in bladder tumors. There was also a significant correlation in expression among pAkt, PTEN, and L-plastin. Although the expression of these genes correlated with factors known to be associated with patient outcome, none of them was an independent predictor of progression-free or overall survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288642      PMCID: PMC4321940          DOI: 10.1002/mc.20420

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  32 in total

1.  Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis.

Authors:  Jian-Min Tang; Quan-Ying He; Rui-Xia Guo; Xiu-Jun Chang
Journal:  Lung Cancer       Date:  2006-02       Impact factor: 5.705

2.  Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.

Authors:  Lan Mo; Xiaoyong Zheng; Hong-Ying Huang; Ellen Shapiro; Herbert Lepor; Carlos Cordon-Cardo; Tung-Tien Sun; Xue-Ru Wu
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

3.  The Akt pathway in human breast cancer: a tissue-array-based analysis.

Authors:  Shikha Bose; Sindhu Chandran; James M Mirocha; Namrata Bose
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

4.  Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis.

Authors:  M Otsuka; M Kato; T Yoshikawa; H Chen; E J Brown; Y Masuho; M Omata; N Seki
Journal:  Biochem Biophys Res Commun       Date:  2001-12-14       Impact factor: 3.575

5.  Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis.

Authors:  Akihiko Ito; Yu-Ichiro Koma; Kazuya Uchino; Tomoyo Okada; Chiho Ohbayashi; Noriaki Tsubota; Morihito Okada
Journal:  Cancer Lett       Date:  2006-03-28       Impact factor: 8.679

6.  Upregulation of L-plastin gene by testosterone in breast and prostate cancer cells: identification of three cooperative androgen receptor-binding sequences.

Authors:  C S Lin; A Lau; C C Yeh; C H Chang; T F Lue
Journal:  DNA Cell Biol       Date:  2000-01       Impact factor: 3.311

7.  Expression patterns of L-plastin isoform in normal and carcinomatous breast tissues.

Authors:  A Lapillonne; O Coué; E Friederich; A Nicolas; L Del Maestro; D Louvard; S Robine; X Sastre-Garau
Journal:  Anticancer Res       Date:  2000 Sep-Oct       Impact factor: 2.480

8.  Potential markers that complement expression of CA125 in epithelial ovarian cancer.

Authors:  Daniel G Rosen; Lin Wang; J Neeley Atkinson; Yinhua Yu; Karen H Lu; Eleftherios P Diamandis; Ingegerd Hellstrom; Samuel C Mok; Jinsong Liu; Robert C Bast
Journal:  Gynecol Oncol       Date:  2005-08-02       Impact factor: 5.482

9.  Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells.

Authors:  Motoyoshi Tanaka; H Barton Grossman
Journal:  Oncol Rep       Date:  2004-02       Impact factor: 3.906

10.  In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.

Authors:  M Tanaka; H B Grossman
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

View more
  17 in total

1.  Identification of genes correlated with early-stage bladder cancer progression.

Authors:  Randolph Stone; Anita L Sabichi; Jennifer Gill; I-Ling Lee; Patrick Adegboyega; Michael S Dai; Raja Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

2.  Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers.

Authors:  Hojung Lee; Seung Kyu Choi; Jae Y Ro
Journal:  Oncol Lett       Date:  2011-12-13       Impact factor: 2.967

3.  Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.

Authors:  Harika Sabbineni; Abdulrahman Alwhaibi; Anna Goc; Fei Gao; Alanna Pruitt; Payaningal R Somanath
Journal:  Eur J Pharmacol       Date:  2015-07-03       Impact factor: 4.432

Review 4.  Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression.

Authors:  David J McConkey; Sangkyou Lee; Woonyoung Choi; Mai Tran; Tadeusz Majewski; Sooyong Lee; Arlene Siefker-Radtke; Colin Dinney; Bogdan Czerniak
Journal:  Urol Oncol       Date:  2010 Jul-Aug       Impact factor: 3.498

5.  Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.

Authors:  Luciana Schultz; Roula Albadine; Jessica Hicks; Sana Jadallah; Angelo M DeMarzo; Ying-Bei Chen; Matthew E Nielsen; Matthew E Neilsen; Mark L Gonzalgo; David Sidransky; Mark Schoenberg; George J Netto
Journal:  Cancer       Date:  2010-10-11       Impact factor: 6.860

6.  Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma.

Authors:  Marie-Lisa Eich; Aline C Tregnago; Sheila F Faraj; Doreen N Palsgrove; Kazutoshi Fujita; Stephania M Bezerra; Enrico Munari; Rajni Sharma; Alcides Chaux; George J Netto
Journal:  Virchows Arch       Date:  2018-10-18       Impact factor: 4.064

7.  Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder.

Authors:  Nilda D Gonzalez-Roibon; Alcides Chaux; Turki Al-Hussain; Adeboye O Osunkoya; Stephania Martins Bezerra; Jessica Hicks; Jonathan I Epstein; George J Netto
Journal:  Hum Pathol       Date:  2012-10-17       Impact factor: 3.466

8.  Phosphatidylinositol 3'-kinase, mTOR, and glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cells.

Authors:  Nicole L Yohn; Caitlyn N Bingaman; Ashley L DuMont; Lina I Yoo
Journal:  BMC Urol       Date:  2011-08-24       Impact factor: 2.264

9.  Plastin family of actin-bundling proteins: its functions in leukocytes, neurons, intestines, and cancer.

Authors:  Hiroto Shinomiya
Journal:  Int J Cell Biol       Date:  2012-01-04

10.  The mouse cyclophosphamide model of bladder pain syndrome: tissue characterization, immune profiling, and relationship to metabotropic glutamate receptors.

Authors:  Anna V Golubeva; Alexander V Zhdanov; Giuseppe Mallel; Timothy G Dinan; John F Cryan
Journal:  Physiol Rep       Date:  2014-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.